AVSOLA

Amgen Canada Inc🇨🇦 Health Canada

Approval Id: f905565d46a069db
Drug Approval Canada Name: AVSOLA
Product Name: AVSOLA
Status: Marketed
Status Date: 2020-06-01
Original Market Date: 2020-06-01
Din: 02496933
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 90:24.16.92
Atc Original: L04AB02 INFLIXIMAB
Atc Name: l 04 ab 02
Aig Number: 0144162001
Company Name: Amgen Canada Inc
Company Address: 300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4

INFLIXIMAB

100 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f905565d46a069db

Type

Standard